PHARMACY

FDA approves J&J’s Doxil as breast cancer drug in tandem with Sanofi-Aventis’ Taxotere

BY Alaric DeArment

NEW YORK Johnson & Johnson has requested approval from the Food and Drug Administration to market its drug Doxil with Sanofi-Aventis’ Taxotere as a treatment for breast cancer, the company has announced.

The two drugs would be used to treat patients who have received chemotherapy. In a clinical trial, they slowed breast cancer’s progression more than Taxotere (docetaxel) alone.

The FDA has approved Doxil (doxorubicin) to treat ovarian cancer, Kaposi’s sarcoma and plasma cell cancer, when used in combination with Millennium Pharmaceuticals’ Velcade.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Judge orders Ely Lilly to unseal Zyprexa documents

BY Alaric DeArment

NEW YORK A judge in the United States District Court for the Eastern District of New York said Friday he would unseal documents concerning Zyprexa, Eli Lilly’s schizophrenia drug.

Judge Jack Weinstein’s ruling was related to his granting of class-action status to a group of unions, pension funds and insurance companies alleging that the Indianapolis-based drug maker failed to disclose some of the drug’s side effects and marketed it for uses for which regulators had not approved it.

The documents date back to 2004, when several patients sued Lilly, alleging that Zyprexa (olanzapine) caused them to develop diabetes and gain excessive weight.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

New York legislation: pharmacists can administer vaccinations

BY Alaric DeArment

ALBANY, N.Y. Starting Dec. 4, pharmacists can apply to New York’s state government for certification to administer vaccinations, under legislation signed Friday by Gov. David Paterson.

The certifications will cost $100 every three years and require training. The shots will still require prescriptions.

The purpose of the bill, supporters said, was to increase the number of vaccinations in the state; in New York City, this could mean an additional 50,000 elderly.

“Allowing pharmacists to immunize would increase access to vaccinations, as pharmacies are open long hours, on weekends and most holidays,” said Sen. Charles Fuschillo Jr., a Long Island Republican who sponsored the bill.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?